Insights From Technical Analysis
.webp&w=828&q=75)
Telix Pharmaceuticals (ASX: TLX): $1.65B ITM Deal Expands Its Radiopharmaceutical Footprint
Telix Pharmaceuticals (ASX: TLX) has agreed to acquire ITM Isotope Technologies Munich for $1.65 billion, with up to $700 million in contingent consideration, expanding Telix’s isotope supply capabilities and radiopharmaceutical platform.
Po Valley Energy (ASX: PVE) Eyes Multi-Well Future With Fresh Hera Gas Deal
Po Valley Energy (ASX: PVE) signed a new 12-month gas supply deal with Hera Trading and cleared a key regulatory step for its Selva Malvezzi four-well drilling program, backed by record August gas revenue.
.webp&w=828&q=75)
Tungsten Mining NL (ASX: TGN): $50M Funding Advances Watershed Toward 2027 Production
Tungsten Mining NL (ASX: TGN) has raised $50 million to advance its Watershed tungsten project, with a reported 65.9% WO₃ concentrate grade and targeted 2027 production, positioning Tungsten’s project for its next stage of development.
Nanoveu (ASX: NVU): 16nm SoC Milestone and US Patent to Redefine Edge AI
While Nanoveu (ASX: NVU) has yet to release performance data from its 16nm ECS-DoT chip, receiving physical silicon from TSMC validates the design and moves the platform closer to benchmarking, partner evaluation, and potential commercialisation.
Adavale Resources (ASX: ADD): The 20-Month Build of Its Parkes Gold Inventory
Adavale Resources (ASX:ADD) has boosted its Parkes gold inventory to 383,300 ounces, up from zero in under 20 months. London-Victoria grew 228% to 262,700 ounces after Adavale's first independent drilling in 30 years, with satellite deposits and Calarie adding further scale.
Nyrada (ASX: NYR) $14M Capital Raise: Fueling the Path to Global Pharma Partnerships
As Nyrada (ASX: NYR) raises $14 million to advance Xolatryp through Phase IIa trials, the funding extends its development runway and could accelerate clinical milestones, potentially positioning the company for future partnerships with global pharmaceutical companies.